Financial
Aspen delivers strong results and advances its strategic ambitions
Aspen Pharmacare Holdings has reported positive Group interim financial results for the six months ended 31 December 2024.
Press Releases
Aspen announces local availability of Lilly’s Mounjaro
Aspen has announced the availability of Lilly’s tirzepatide, marketed globally as Mounjaro®, a therapeutic option available to physicians for the treatment of Type II diabetes.
Press Releases
Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day
Aspen and SEMDSA earlier today raised awareness around the alarming rise of non-communicable diseases, particularly diabetes, in recognition of World Diabetes Day.
Financial
Aspen to participate in the Investec CEO conference in London
Aspen’s Stephen Saad and Sean Capazorio will take part in Investec’s CEO conference in London from 14 to 15 November 2024.
SED Initiatives
Aspen partners with PinkDrive to mobilise cancer screening
Aspen has contributed towards the funding of a new mobile cancer screening clinic for rural and peri-urban disadvantaged communities.
Financial
Aspen’s revenue increases 10% underpinned by a strong second half performance
JSE-listed Aspen Pharmacare Holdings Limited (APN), a global multinational specialty pharmaceutical company, has reported solid Group financial results for the year ended 30 June 2024.
SED Initiatives
Aspen’s Mandela Day programme changes more than 910 000 lives over 14 years
Durban – JSE Limited listed Aspen Pharmacare Holdings Limited (“Aspen”), a global specialty and branded pharmaceutical company, is celebrating its 14th consecutive year of Group-wide participation in Mandela Day. Stephen Saad, Aspen Group Chief Executive said, “ Aspen has a track record of improving access to healthcare to all patients but more particularly the most vulnerable among us. This spirit of care extends beyond healthcare to many socio-economic development (“SED”) initiatives. We have so many challenges to address, that it can seem overwhelming. However, with one step at a time, we can move forward. Today, we celebrate serving more than 910 000 individuals through projects across more than 40 countries, and I honour our employees who are at the very heart of making a difference and who are the heroes of our Mandela Day programme. With every 10th person in the world impacted by poverty[1], we recognise that every effort, no matter how big or small, offers a promise of hope to those in need.” “We remain committed to an unwavering humanitarian spirit and actions that demonstrate generosity, humility and care and encourage others to join us and help make a difference to the most vulnerable among us,” added Saad. Aspen’s Mandela Day programme, recognised as the Group’s flagship SED campaign, was initiated in 2011 and has focused on partnering with worthy beneficiaries across the six continents where Aspen has a business presence. The programme has assisted in providing relief to abandoned, neglected, orphaned or abused babies, children and women; the elderly, hungry and homeless; individuals inflicted with mental wellness challenges; students who strive to achieve academically; those who are disabled; victims of political conflict; residents at social rehabilitation institutions; healthcare facility patients who need support and equipment; environmental and climate challenges; and inequality, among others. [1] https://ourworldindata.org/poverty
SED Initiatives
Aspen backs Donald Ramphadi to bring home the gold in upcoming mobility impaired tennis championships
Johannesburg, South Africa – Aspen Pharmacare Holdings Limited (“Aspen”), a global multinational specialty pharmaceutical company, has presented a state-of-the-art high performance wheelchair to South African wheelchair tennis star Donald Ramphadi. Ramphadi, a French-open double quads champion and a prominent figure in wheelchair tennis, reached his maiden Grand Slam final at the Australian Open Wheelchair Championships in January 2024. He is undeterred by his impaired mobility and his fourth place single quads ranking by the International Tennis Federation is testament to his talent. On the occasion of the presentation, Stavros Nicolaou, Aspen Senior Executive Strategic Trade said, “Aspen is honoured to support Donald Ramphadi ahead of his 2024 season when he takes to international courts to defend his title at the Paris Paralympics in France, among many others. We also laud Donald for his nomination in the 2024 South African Sports Awards’ Sportsman of the Year with a Disability category. In recent years we recognized Donald’s exceptional athletic talent, his unwavering dedication to wheelchair tennis and his dreams of bringing back gold for South Africa. Aspen subsequently facilitated the customisation and provision of a state-of-the-art high performance wheelchair tailored to his unique requirements to assist him in reaching his athletic goals. This action endorses Aspen’s commitment to inclusivity, accessibility, and the empowerment of athletes with disabilities. It is also aligned to our philosophy of embracing sports, arts and culture as powerful unifiers to promote healthy lifestyles and reduce the disease burden on our healthcare system.” An overjoyed Donald Ramphadi said, “I am so grateful for this generous donation from Aspen which is a major boost ahead of the 2024 Paris Paralympics in France. I’ve previously played in matches where I’ve had to retire my lead because of my wheelchair which naturally shattered many dreams. I’m excited about this wheelchair and I’m more determined than ever to up my game and take everything that I can in the upcoming tournaments that I compete in.”
Media Enquiries
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com